Foresite Capital, San Francisco is a healthcare growth equity and venture capital firm. The firm has a reputation of investing in most of the world’s exciting, inventive and innovative healthcare firms. The firm provides emerging healthcare leaders with distinctive products and services with growth capital with the aim of expanding the health sector in both private and public markets. The firm also has an office in New York, and it recently added Dr. Molly He as a venture partner. Molly He Ph.D. brings to the company over fifteen years of vast experience in the pharmaceutical research and development and thus she is an invaluable resource to the firm.
Jim Tananbaum is the founder, managing director, and chief executive officer, of Foresite capital. Foresite Capital is a venture capital firm which mainly specializes in healthcare. Jim has been associated with the company for seven years since 2010. However, Tananbaum has over twenty-five years of experience in the venture capital industry, which he has used to place the firm in the top position of the best and improving firms’ list. Before forming Foresite Capital, he was part and parcel of Sierra Ventures and the famous Prospect Partners Ventures both two and three. His previous association with such firms gives a clear record of the vast experience he has in the venture capital industry.
Jim Tananbaum is an alumnus of the Yale University and Harvard Business School. His Twitter, Jim is a holder of a Bachelor’s degree in Economics from Yale University, a Master’s degree in Business Administration from Harvard Business School, and also an MD which he attained from the Harvard Medical School. The MD enabled him to specialize his venture capital firm in healthcare matters. Other than Foresite Capital, his other significant and notable investments include Healtheon, Amira Pharmaceuticals, Jazz Pharmaceuticals, and the Amerigroup. Most of his ventures are located in San Francisco Bay Area, and one of his most prominent deals was the Intarcia Therapeutics and learn more about Jim.
More visit: https://www.forbes.com/profile/jim-tananbaum/